عنوان ژورنال
مجله علوم اعصاب شفای خاتم- درجه :علمی پژوهشی وزارت بهداشت
- issn :2322-1887
- ناشر :مرکز تحقیقات علوم اعصاب شفا، بیمارستان خاتم الانبیا تهران
شماره 2 تاریخ انتشار 2017-04
- Abstract Book of the 1st International Neuroinflammation Congress and 1st Student Festival of Neurosience
- O 1: The Effects of Vitamin D Supplementation on the T cell Compartment in Multiple Sclerosis
- O 2: Anti-Inflammatory Approach to Epilepsy Treatment
- O 3:Therapeutic Potential of a Novel NMDA Receptor Subunit 2B Antagonist in a Mouse Model of Autoimmune Neuroinflammation
- O 4: Kynurenine Impairs MbMEC Function in Vitro Through Arylhydrocarbon Receptor Activation
- O 5: Coagulation Factors in Multiple Sclerosis may Represent Diagnostic and Therapeutic Strategies
- O 6: Kininogen Deficiency Ameliorates Neuroinflammation by Reducing Immune Cell Trafficking
- O 7: KCNK2 Regulates the Nanoscale Formation of Immune Docking Structures on Brain Endothelial Cells Under Autoinflammatory Conditions
- O 8: Tenasin-C as a New Target for Multiple Sclerosis Treatment
- O 9: Immunomodulatory Effects of Neural Stem Cell on Multiple Sclerosis: A Systematic Review
- O 10: Multiple Sclerosis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options
- O 11: Diagnosis and Management of Neuromyelitis Optica
- O 12: The Pathophysiological Hallmarks of MS Beyond the Blood Brain Barrier: Myelination and Neuronal Network Interactions
- O 13: Ion Channels in Autoimmune Neurodegeneration
- O 14: Differentiating Demyelinating Disorders of the Central Nervous System – a Focus on Multiple Sclerosis and Neuromyelitis-Optica Spectrum Disorders
- O 15: Limbic Encephalitis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options
- O 16: Challenge in Diagnosis and Management of Autoimmune Encephalitis
- O 17: Childhood Anti-NMDA Receptor Encephalitis
- O 18: Autoimmune Dementia
- O 19: Treatment and Porognosis of Autoimmune Encephalitis
- O 20: The Role of Neuroinflammation in Epilepsy: A New Target for Treatment
- O 21: A Case of Anti-NMDA Receptor Encephalitis Who Presented with Status Epilepticus
- O 22: Reactive Oxygen Species and Epilepsy
- O 23: Anti-Inflammatory Treatment in Children with Refractory Seizure
- O 24: Functional Role of The K2p Potassium Channel Task-3 in A Syngeneic Murine Glioma Model
- O 25: Immunotherapy for Brain Tumor
- O 26: Treatment of Traumatic Brain Injury in Adult Rats with Injection of Human Epileptic Neural Stem Cells and Nano-Scaffold
- O 27: Traumatic Brain Injury and Inflammation
- O 28: Autoimmune Myositis: General Aspects of Pathophysiology, Symptoms and Therapeutic Options
- O 29: Autoimmune Myasthenia Gravis Introduction, Immunopathogenesis and Classification
- O 30: Peripheral Nervous System Diseases and Inflammation
- O 31: HTLV-1 and Inflammation
- P 1: Effect of Clavulanic Acid on Trimethyltin-Induced Cytotoxicity in PC12
- P 2: Proliferation of Neural Stem Cells Promotes in Presence of Feijoa Methanolic Extract in the Oxidative Stress Condition
- P 3: The Study about MRI Images of Encephalitis and Diagnosis by Using the Software Ways
- P 4: The Hypothesis Detect Multiple Sclerosis in Early Stage with Saliva Testing
- P 5: The Effect of Previous Endurance Exercise in Traumatic Brain Injury
- P 6: Effect of Voluntary Exercise on Learning and Memory Impairments in Sleep Deprived Female Rats
- P 7: The Effect of Curcumin and Melittin on an Animal Model of MS
- P 8: Affective Factors in the Event Time of Neuropathy in Diabetic Patients (Type II)
- P 9: Neuoprotective Effect of Cannabinoid CB1 Receptor Antagonists Rimonabant and AM251 on Hypoxic Mouse Model of Brain Oxidative Stress
- P 12: Study of the Association between Serum Level of Cystatin C and Behavioral Symptoms of 6-Hydroxydopamine – Induced Parkinsonism in Rat
- P 13: Correlation Between Alanine Aminotransferase Serum (ALT) Level and Behavioral Symptoms of 6-Hydroxydopamine (6-OHDA)-Induced Parkinsonism in Rats
- P 14: CSF NGF/IL-6 Ratio: a Useful Marker for the Evaluation of Progesterone Efficacy in Traumatic Brain Injury
- P 15: Forced Exercise Attenuates Neuropathic Pain in Chronic Constriction Injury Male Rat: An Approach to Oxidative Stress and Inflammation
- P 16: The Effect of Reducing CCL11 on Multiple Sclerosis Treatment by Using Heterochronic Parabiosis Techniques
- P 17: Electrophysiological Effects of Cannabinoid Receptor Antagonist AM251 on Harmaline Toxicity in Rat’s Cerebellar Vermis Slices
- P 18: Alterations of Electrophysiological Activity of Cerebellar Pukinje Cells of Rats Under Harmaline Toxicity
- P 19: The Effects of Aloe Vera Extract on Brain Edema and Blood-Brain Barrier Permeability after Traumatic Brain Injury
- P 20: Neutrophil to Lymphocyte Ratio as a Prognostic Marker in Glioblastoma Multiforme: a Systematic Review and Meta-Analysis
- P 21: Epidemiology of Multiple Sclerosis in Khorasan Razavi Province
- P 22: Antihypoxic Effect of Saffron Extract in Mouse Model of Hypoxic Ischemia
- P 23: Apoptosis Following Cortical Spreading Depression in Juvenile Rats
- P 24: Evaluation of the Voxel Based Morphometry in Quantitative Analysis of Brain MRI Images
- P 25: The Facilitatory Action of Snake Venom Phospholipase A2 Neurotoxins by Which Increase the Release of Acetylcholine, May Improve Alzheimer\'s Disease Symptoms
- P 26: The Protective Effect of Nano-Hesperetin on Memory Disorder Induced by Streptozotocinin Male Rat in Alzheimer Models
- P 27: The Beneficial Effect of Aminoguanidine on Lipopolysaccharide -Induced Memory Impairment and Neuro-Inflammation in Rats
- P 28: Bone Marrow-Derived Mesenchymal Stem Cells Reduces Neuroinflammation and Splenic Cytolytic CD8 + T Cells in Mice with Experimental Autoimmune Encephalomyelitis
- P 29: Effects of Different Doses of Some GABAergic Agents in Mouse Brain Under Hypoxic State: Possible Role in Neuro-Inflammation
- P 30: Effect of Fasudil on Acrylamide-Induced Cytotoxicity in PC12 Cells Through Evaluation of ROS and MTT Test
- P 31: Reduce Inflammation and Hypothalamic Disorders in Patients with Multiple Sclerosis
- P 32: The Role of CB2 Activation in Rats Under Harmaline Toxicity
- P 33: Effect of Alcoholic Extract of Rosmarinus officinalis L. and Rosmarinic Acid on Inflammation Induced by Chronic Constriction Injury (CCI) Model of Neuropathic Pain in Rats
- P 34: Evidence of Panax Ginseng in Multiple Sclerosis
- P 35: The Mediating Role of Meta-Cognitive Beliefs on the Cognitive-Executive Functions of Brain, Sleep Disorders, Optic Neuritis in Multiple Sclerosis Patients
- P 36: Protective Effects of Crocin on D-Galactose Induced Aging Model in Human Neuroblastoma Cells
- P 37: Prescribing Pepper for Stroke Treatment
- P 38: The Relationship between Personality Traits and Cortisol Levels and TGF-B in Patients with Multiple Sclerosis Have Optic Neuritis (Optic Neuritis)
- P 39: Screening of Anxiety, Depression and Quality of Life in Epileptic Patients and Their Family
- P 40: Neuroprotective Effects of Saffron Extract in Rat Brain Under Ischemia Reperfusion Model
- P 41: Meningioma Stem Like Cells and Self Assembling Nanopeptide Scaffold for Treatment of Traumatic Brain Injury in Animal Model
- P 42: Effect of Hesperetin During Pregnancy and Lactation on Locomotor Activity and Anxiety-Like Behaviors in Animal Model of Autism
- P 43: The Role of TWIK2 Channels on Immune Cells and its Impact in EAE/ MS Pathophysiology
- P 44: The Role of HCN Channels in T Cell Function
- P 45: De- and Remyelination Affect Cognitive and Locomotor Abilities in Mice
- P 46: The Role of Kv7-Channels in the Pathophysiology of Multiple Sclerosis
- P 47: Occupational Toxins and Neuroinflammation
- P 48: Pioglitazone in Early Parkinson: A Review Study
- P 49: Exercise Effects on Cognitive Impairments Through Altering Neuroinflammation
- P 50: A Review on the Role and Efficacy of Vitamins in Depression
- P 51: The Role of T Helper 17 in Pathogenesis of Multiple Sclerosis
- P 52: Interferon beta-a1 vs. Teriflunomide for Multiple Sclerosis
- P 53: Stem Cell Therapy for Treatment of Autoimmune Diseases (with Emphasis on Multiple Sclerosis)
- P 54: Migraine: a Brain Plasticity Response to Repetitive Stressful Occurrences
- P 55: Sleep Disturbance and Epilepsy: an Inflammatory Pathway
- P 56: Inhibitory Effects of Curcumin, a Regulator of CD4+ T Helper Cell, on HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
- P 57: The Effect of Biotin as a Therapeutic Agent for Progressive Multiple Sclerosis
- P 58: Herbal Medicine “Ginseng” as Therapy and Prevention of Parkinson`s Disease
- P 59: Non-Steroidal Anti-Inflammatory Drugs as a Prevention of Alzheimer Disease: Risks and Benefits
- P 60: The Effect of Melatonin as a Therapeutic Goal on Multiple Sclerosis Through Immune Processes
- P 61: MicroRNA as a Therapeutic Tool to Prevent Blood Brain Barrier Dysfunction in Neuroinflammation
- P 62: Markers of Neuroinflammation Related to Alzheimer\'s Disease Pathology in the Elderly
- P 63: Role of Neuroinflammation in Depression
- P 64: Micro-Rna Disorder and Multiple Sclerosis
- P 65: Soluble CD18 as an Inflammation Reducing Agent in Parkinson\'s Disease
- P 66: A Review of Novel Biomarkers Involved in the Neuroinflammation Caused by Human T Lymphotropic Virus-1
- P 67: The Role of Neuroinflammation in Dysfunction of Adult Hippocampal Neurogenesis
- P 68: The Role of Neuroinflammation in Post-Traumatic Stress Disorder (PTSD)
- P 69: Effect of Serum Zinc Element in Epilepsy Paitaints
- P 70: Primary Progressive MS and Affecting Genes
- P 71: A Review on the Role and Efficacy of Vitamins in Depression
- P 72: Serological Changes of Cytokines, in Diagnosing and Treatment Children with Autism
- P 73: The Effect of Hypnotherapy and Cognitive Therapy in Management of Multiple Sclerosis Pain
- P 74: Neuro-Inflammation and Quality of Life-A Narrative Review
- P 75: Inflammation in the Pathogenesis of Depression
- P 76: Assay of Alterations of Cytokines to Remedy of Traumatic Brain Injury
- P 77: The Role of Interleukin-1 in Neurogenesis and Alzheimer Disease
- P 78: The Role of Kynurenine Pathway in Suicidal Behavior and Depression
- P 79: Neuroinflammation: A Common Phenomenon between Chronic Pain and Opioids
- P 80: Effects of Vitamin D on Migraine
- P 81: Omega-3 Fatty Acid and Oxylipins in Management of Alzheimer Disease
- P 82: The Transplantation of Human Umbilical Cord Mesenchymal Stem Cells in Neonatal Strokes
- P 83: Progression of Hearing Loss in Experimental Meningitis
- P 84: Daily Nutrition has a Grand but Inapparent Effect on the Procedure of Inflammatory Dementia
- P 85: Anticonvulsant Activity of the Leaves of Glycyrrhiza-Glabra Var. Glandulifera and Antioxidant Effect of Achillea Wilhelmsii in Epilepsy Treatment
- P 86: CD166 as a Therapeutic Target in Autoimmune Diseases
- P 88: Matrix Metalloproteinases in Neuroinflammation
- P 89: Reduction of Neuroinflammation in Epilepsy by Using Stem Cells Derived Astrocytes
- P 90: The Role of miR-146a in Inflammatory Process of Mesial Temporal Lobe Epilepsy (MTLE): Implication for Therapy
- P 91: The Evaluation of Serum Level of 25-Hydroxy Vitamin D in Patients under Sodium Valproate Medication
- P 92: A Critical Balance between Repair and Demolish of Proinflammatory Factors to Improve Effects of Neuroinflammation
- P 93: The Role of Marine Compounds in Neuroinflammation
- P 94: The Systemic Inflammation after Spinal Cord Injury
- P 95: Result of Alcohol Excessive Drinking in the Brain and Varying Mental Health Side Effects
- P 96: Role of Thrombin in Inflammatory Central Nervous System (CNS) Diseases
- P 97: Neurodegeneration Induced by Tau protein
- P 98: Neuroinflammation and Nanomedicine,How about Cerebral Palsy
- P 99: Self-Assembling Peptide Scaffolds as New Therapeutic Method in TBI: Focused on Bioactive Motifs
- P 100: Stem Cells as Neuroinflammatory Modulator in TBI: A Narrative Review
- P 101: Ginger and Honey Mixture as an Anti-Inflammatory Drug in Neuroinflammation:Alzheimer Disease
- P 102: The Study of Some Factors Which Effect on Beta-Amyloid Signaling in Neuroinflammation
- P 103: Effects of Physical Exercise on Neuroinflammation
- P 104: Effects of Human Neural Stem Cells in Cure Neuroinflammation of Traumatic Brain Injury
- P 105: The Role of LRRK2 Inhibitors in Treatment of Parkinson’s Disease
- P 106: Effects of Dimethyl Sulfoxide on NLRP3 Inflammasome and Alzheimer\'s Disease
- P 107: P2x7 Receptors: as a Novel Targets for the Treatment of Neuroinflammation
- P 108: Evaluation of Calcineurin Role in Neuroinflmmation: Possible Targets for Early Detection and Treatment
- P 109: The Potential Preventive-Therapeutic Effects of Flavonol Consumption on Alzheimer\'s Disease
- P 110: Evaluating the Role of Histone Hyper Acetylation in Induction of Neuroinflammation
- P 111: Use of Stem Cell Therapy for Treatment of Temporal Lobe Epilepsy (TLE)
- P 112: Combining Granulocyte-Colony Stimulating Factor (G-CSF) and Stem Cells in Treatment of Traumatic Brain Injury (TBI)
- P 113: Effect of Curcumin on Microglial Cells in MS
- P 114: The Impact of Chamomile on Parkinson Disease (PD)
- P 115: Potential Therapeutic Targets Related to Neuroinflammation in Treatment and Prevention of Autism
- P 116: The Effect of Galectin-3 and Lanthionine Ketimine Ester in Neural Recovery after Spinal Cord Injury
- P 117: Endocannabinoid System as a Novel Therapeutic Target in Epilepsy
- P 118: Osteopontin: An Early Player in Neuroinflammation Disease
- P 119: Role of Gut Bacteria on Alzheimer’s Disease
- P 120: The Effect of Steroids on the Optic Neuritis in MS
- P 121: Neuroinflammation and Diabetes
- P 122: Dietary Habits and Multiple Sclerosis
- P 123: A Promising Approach in Inflammation Management, Cytokine Therapy for Alzheimer’s Disease
- P 124: Decrease Signs Parkinson`s Disease with DOPAMINE in Apple
- P 125: Treatment of Multiple Sclerosis with Mesenchymal Cells Starfish
- P 126: The Relationship between Bell`s Palsy and Diabetes
- P 127: The Role of CGRP in Dental Pulp Nerve repair
- P 128: Sleep Disturbance and Epilepsy: An Inflammatory Pathway
- P 129: The Role of Overexpression Transcription Factor BRN 4 in Multiple Sclerosis
- P 130: The Role of Host T- Cell Lymphocyte in Immunopathogenesis of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis
- P 131: Connection Process Inflammation and Improvement Alzheimer’s Disease
- P 132: The Role of Depression in Prevention or Therapy of Neuroinflammatory Diseases
- P 133: Neuroinflammation in Alzheimer ’s Disease
- P 134: Use of Zinc in Drugs to Improve Neuroinflammation Disease
- P 135: The Effects of Exercise on Treatment of Neuroinflammatory Disorders
- P 136: The Role of Blood Brain Barrier in Multiple Sclerosis
- P 137: Central Nervous System Involvement in Systemic Lupus Erythematosus
- P 138: Improving Neuroplasticity Through Neuroinflammation Pathways as a Therapeutic Goal in the Treatment of Autism
- P 139: Curcumin anti-Inflammatory Effect in Neuroinflammatory Disorders: Prospective and Challenges
- P 140: Stem Cells in Multiple Sclerosis
- P 141: Mesenchymal Stem Cells as Treatment in Neuroinflammatory Disease
- P 142: Air Pollution\'s Triggering Role in Tau Protein Hyper Phosphorylation; A Sign of Alzheimer Disease
- P 143: The Effect of Platelet Activating Factor on Inflammatory Response in Multiple Sclerosis
- P 144: Sunflower Mannose binding Lectin-Associated Serine Protease Inhibitor-1 (SFMI-1) and -2: Significant Inhibitors of Mannose binding Lectin Pathway which Helps in Multiple Sclerosis Treatment
- P 145: A Review of Animal Models of Absence Epilepsy
- P 146: The Best New Antiepileptic Drugs to Prevent Orofacial Malformations as Side Effects of Antiepileptic Drugs
- P 147: Role of Sparstolonin B in Intracerebral Hemorrhage-Induced Inflammatory Brain Injury: Blocking the Formation of TLR2/TLR4 Heterodimer
- P 148: The Role of Cannabinoids in Ischemia Stroke
- P 149: Effect of Glycoprotein IIb/IIIa Inhibition on Acute Ischemic Stroke Injuries
- P 150: The Role of Blood Brain Barrier Restoration in the Multiple Sclerosis
- P 151: Clinical Trial in Cell Therapy of Multiple Sclerosis
- P 152: Mesenchymal Stem Cells as a Therapeutic Target in Multiple Sclerosis
- P 153: Neuroinflammation in Multiple Sclerosis
- P 154: The Role of Inflammation in the Seizure Occurrence
- P 155: The Roles of Microglia in Neurodegenerative Diseases
دوره